Jed Castillo, MD
Surgery · Los Angeles, CANPI 1801275920
Payments from drug & device makers
Across 52 payments — averaging $219.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- New Wave Endo-surgical Corp.$464
- Medtronic$334
- Medical Device Business Services, Inc.$305
- Boston Scientific$175
- Cvrx, Inc.$169
- plus $803 from 13 others
What the payments were for
- Travel & lodging$2,88025%
- Food & beverage$2,20619%
- Education$6,30555%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 27 | $9,140 |
| New Wave Endo-surgical Corp. | 1 | $464 |
| Medtronic | 7 | $334 |
| Medical Device Business Services, Inc. | 1 | $305 |
| Boston Scientific | 1 | $175 |
| Cvrx, Inc. | 1 | $169 |
| AbbVie | 1 | $150 |
| Heron Therapeutics, Inc. | 2 | $148 |
| Bayer | 1 | $124 |
| Teleflex LLC | 1 | $82 |
| Abiomed | 1 | $58 |
| Solventum Corporation | 1 | $53 |
| Mindray DS USA, Inc. | 1 | $38 |
| Johnson & Johnson | 1 | $33 |
| Merck | 1 | $31 |
| Davol Inc. | 1 | $28 |
| Integra Lifesciences Corporation | 1 | $21 |
| W. L. Gore & Associates, Inc. | 1 | $20 |
| Abbott | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$6,000
- Da Vinci Surgical System$2,867
- ELUVIA$175
- Barostim Neo System$169
- UBRELVY$150
- Zynrelef$124
- Kerendia$124
How this compares
$11,390 in reported general payments places this provider in the 75th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 11 | $609 |
| Pantoprazole Sodium | 11 | $100 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $64 |
Paid to pharmacies, not to this prescriber.
Other surgery in Los Angeles
- John LiphamLos Angeles$991K
- Caitlin HoughtonLos Angeles$643K
- Nikolai BildzukewiczLos Angeles$348K
- Miguel BurchLos Angeles$290K
- Peyman BenharashLos Angeles$218K
- Raul RosenthalLos Angeles$210K
- Timothy DonahueLos Angeles$200K
- Timothy ChuterSan Francisco$8.9M
- Peter StockSan Francisco$6.5M
- Santiago HorganSan Diego$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.